This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Assura bidding battle puts focus on likelihood of UK merger approval

By Jon Menon ( May 19, 2025, 15:58 GMT | Comment) -- A bidding battle for Assura, a UK real estate company that invests in doctors’ clinics, has brought the potential involvement of the UK antitrust regulator to the fore. Primary Health Properties on Friday raised its offer to 1.68 billion pounds, outbidding a rival approach from Kohlberg Kravis Roberts and Stonepeak Partners. It has also said CMA approval won't be a condition of the deal. KKR, for its part, says PHP's bid risks being undone by antitrust concerns.A bidding war for Assura, a British real estate company that invests in doctors’ clinics, has seen the potential involvement of the UK merger regulator emerge as something of a bargaining chip....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login